Used in more countries around the world than any other seed technology the Magseed® marker has been subject to numerous regulatory approvals, clinical trials, new product evaluations and appeared in numerous peer-reviewed papers.
Here you can read these clinical assessments in full and see how Magseed® marker compares to alternative technologies.
This study from MD Anderson Cancer Center demonstrates the efficacy of the Magseed® marker for breast lymph node marking post Neoadjuvant Chemotherapy
This meta analysis found that Magseed is a non-inferior, reliable and effective radiation-free localisation alternative to WGL, widely accepted by physicians as it decouples radiology and surgery schedules.
This study was the largest non-radioactive seed series in the world, demonstrating a highly successful Magseed® marker program implementation.
This prospective single center study from MD Anderson Cancer Center concludes that the Magseed® marker is safe and effective for localisation and excision of non-palpable breast lesions
This study from the Royal Marsden Hospital investigates patient and clinician satisfaction and clinical outcomes for Magseed® localization, demonstrating a clinician preference for Magseed® and a reduction in patient anxiety
This multi-center concludes that the Magseed® marker is a reliable marker for breast tumors and pathological axillary node localization in breast cancer patients.
This study from Charité hospital in Berlin, Germany concludes that the Magseed® marker is superior to WGL for patient comfort and reduces operative time.
This study investigated the feasibility and efficacy of Magseed®, concluding it to be simple to use and that it consents short lumpectomy time, whilst improving the care pathway and organization of both radiological and surgical teams
This study evaluates the early adoption of the Magseed® marker compared to hookwire lesion localisation
This study shows that the Magseed® marker is a safe, easy technique with a short learning curve, with efficient use of clinical resources
This study shows that Magseed® marker localization is a safe, nonradioactive way to accurately localize axillary lymph nodes preoperatively
This study demonstrates accurate lesion localisation and SLN detection with the combined use of the Magseed® marker and Magtrace® lymphatic tracer
This study demonstrates the combined use of the Magseed® marker and Magtrace® lymphatic tracer for lesion localisation and SLNB
This study shows that the Magseed® marker can be accurately placed, demonstrates no migration and is detectable in all sizes and depths of breast tissue
This study – featuring 188 patients – shows that Magseed® marker localisation has the potential to replace conventional wire needle localisation
This study demonstrates the benefits of implementing a Magseed® marker program into a large hospital facility.
This study from UCSF shows that the Magseed® marker provides an effective means for preoperative localisation of non-palpable breast lesions
If you would like to read additional literature relating to the Magseed® marker and its safety, effectiveness and clinical results, please get in touch and we will be happy to assist you.